Unicycive Therapeutics, Inc. - stock earnings
UNCY Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -4.4 million USD | ? USD |
| 2023Q2 | -3.8 million USD | ? USD |
| 2023Q1 | -25.2 million USD | 675000 USD |
| 2022Q4 | -5.3 million USD | ? USD |
| 2022Q3 | -5.6 million USD | 951000 USD |
| 2022Q2 | -3.6 million USD | ? USD |
| 2022Q1 | -3.5 million USD | ? USD |
| 2021Q4 | -2.8 million USD | ? USD |
| 2021Q3 | -5.2 million USD | ? USD |
| 2021Q2 | -1.1 million USD | ? USD |
| 2021Q1 | -964000 USD | ? USD |
| 2020Q4 | -880000 USD | ? USD |
| 2020Q3 | -702000 USD | ? USD |
| 2020Q2 | -338000 USD | ? USD |
| 2020Q1 | -344000 USD | ? USD |
UNCY Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -28.1 million USD | 675000 USD |
| 2022 | -18.1 million USD | 951000 USD |
| 2021 | -10.6 million USD | ? USD |
| 2020 | -2.5 million USD | ? USD |
| 2019 | -2.3 million USD | ? USD |
| 2018 | -1.1 million USD | ? USD |
UNCY
Price: $1.22
52 week price:
Earnings Per Share: -1.47 USD
P/E Ratio: -0.76
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 23619
Market Capitalization: 45.2 million